222 Berkeley Street, Suite 1200, Boston, Massachusetts, United States, 02116
Company Detail Path
/organization/rhythm-pharmaceuticals
Company Information
Pharmaceutical Company Name
Rhythm Pharmaceuticals
Name En
Rhythm Pharmaceuticals
Name Zh
Rhythm Pharmaceuticals
Country Name
United States
Province Name
Massachusetts
City Name
boston,massachusetts,country_us
Address
222 Berkeley St Ste 1200
Website
http://www.rhythmtx.com
Description
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.
